Ernst Schering Research Foundation Workshop
DOI: 10.1007/978-3-540-49527-7_5
|View full text |Cite
|
Sign up to set email alerts
|

[18F]Fluoropyridines: From Conventional Radiotracers to the Labeling of Macromolecules Such as Proteins and Oligonucleotides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 109 publications
1
16
0
Order By: Relevance
“…31 However, we observe some bone uptake with [ 18 F]- 5 (1.31 ± 0.63 %ID/g) and [ 18 F]- 4a (4.14 ± 1.12 %ID/g) 2h p. i.. In comparison, [ 18 F]-Fluoropentyne based prosthetic group shows very minimal bone uptake (0.39 %ID/g at 1h p.i.).…”
Section: Resultsmentioning
confidence: 64%
See 1 more Smart Citation
“…31 However, we observe some bone uptake with [ 18 F]- 5 (1.31 ± 0.63 %ID/g) and [ 18 F]- 4a (4.14 ± 1.12 %ID/g) 2h p. i.. In comparison, [ 18 F]-Fluoropentyne based prosthetic group shows very minimal bone uptake (0.39 %ID/g at 1h p.i.).…”
Section: Resultsmentioning
confidence: 64%
“…We chose Fluoropyridinealkyne 3 because of the commercial availability of the corresponding bromo-precursor 6 , its UV-detectability, and the fact that 2-[ 18 F]fluoropyridines were shown to display high in vivo stability. 31 Moreover, the small size of 3 was expected to have a very limited impact on the pharmacokinetic of peptides as large as pHLIP.…”
Section: Resultsmentioning
confidence: 99%
“…Compared with other radiotracers, the 18 F radiotracer could improve stability and bioavailability of tissue metabolism, enhance the bonding force, and reduce the plasma protein binding rate [44]. Incorporating 18 F into a compound alters the lipophilic parameter and might increase the intrinsic activity, metabolic stability, and bioavailability [45].…”
Section: Mitochondrial-targeted Pet Agentsmentioning
confidence: 99%
“…18 F labeled siRNA analogs for PET imaging). Fluorine-18 labeled oligonucleotides have been already tested as labeled imaging probes in vivo (Boisgard et al, 2005; Dolle, 2007). With the development of more quantitative in vivo imaging experiments the current animal studies involving siRNA could be either complemented with, or replaced entirely by survival (and longitudinal) imaging studies.…”
Section: Assessment Of Rnai Delivery Using Imagingmentioning
confidence: 99%